Skip to content

Analgesia in Total Hip Arthroplasty by Quadratus Lumborum Block

Comparison of the Clinical Effectiveness of the Quadratus Lumborum Block and Femoral Block in the Analgesia of Total Posterior Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03666260
Acronym
ATHAQLuB
Enrollment
179
Registered
2018-09-11
Start date
2018-10-08
Completion date
2021-07-09
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Replacement Surgery

Keywords

Total hip replacement surgery, post operative pain, quadratus lumborum block, femoral block

Brief summary

Patients are painful after total hip arthroplasty. These patients have significant co-morbidities. Analgesics cause significant side effects in this population. Locoregional analgesia is therefore an effective means of reducing the consumption of opioids in this surgery. The gold standard of locoregional analgesia after Total Hip Arthroplasty is the femoral block. However, a new technique has recently been described: the Quadratus Lumborum Block. The comparison of these two techniques is lacking in the literature. The comparison of the Quadratus Lumborum Block to the femoral block in Total Hip arthroplasty is important in the analgesic strategy of patients undergoing this surgery.

Detailed description

The aim of this study is to compare the clinical efficacy of two regional locoregional analgesia strategies in total hip replacement surgery: the ultrasound-guided Quadratus Lumborum Block and the ultrasound-guided femoral block. This is a double-blind, randomized study in prospective inclusion with a superiority test. Two groups of patients will be compared: a group of patients with a quadratus lumborum block and a group of patients with a femoral block. Management (quadratus lumborum block or femoral block) will be randomized. The randomization will be stratified on the type of anesthesia (spinal anesthesia and general anesthesia). Randomization will be done on the day of surgery to determine the patient's treatment group. The surgical procedure will not be modified by the participation of the patent in the study. Patients who would benefit from total hip replacement surgery in the Reims University Hospital and who agreed to participate in the study were included.

Interventions

PROCEDUREQuadratus Lumborum Block

Quadratus Lumborum Block with echography

PROCEDUREfemoral block

femoral block with echography

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients eligible for total hip replacement surgery in Reims University Hospital * Patients agreeing to participate in the research and having signed informed consent * between 18 yo and 95 yo * Patients affiliated to a social security system

Exclusion criteria

* Patients with allergy to local anesthetics * Patients with neuropathy * Patients with an ASA score of 4 * Patients undergoing revision surgery for total hip arthroplasty * Patients receiving anterior hip total hip replacement surgery * Patients with a contraindication to the realization of the quadratus lumborum block, femoral block or spinal anesthesia (clinical coagulopathy, infection at the point of puncture ...) * Patients refusing the proposed techniques

Design outcomes

Primary

MeasureTime frameDescription
morphine consumption24 hoursMorphine consumption during the 24 hours postoperative

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026